Data as of .
CRCA vs CRCG: which held to its multiple?
Over the days both have traded, CRCA finished 6.4 points from its stated multiple and CRCG 6.4.
ETFIQ Decay Resistance Score: CRCG scores higher
Did it keep up with its own daily multiple, compounded day by day?
A percentile among the 391 leveraged ETFs, long, over three months. It is a position in a set, not a rating, and neither end of it is a recommendation. All leveraged ETFs ranked by it · How it is computed
Performance, window by window
| Window | Total return | Multiple would give | Difference | |||
|---|---|---|---|---|---|---|
| CRCA | CRCG | CRCA | CRCG | CRCA | CRCG | |
| 1 month | +47.8% | +47.8% | +54.2% | +54.2% | −6.4 pts | −6.4 pts |
| 3 months | +4.9% | +5.8% | +32.8% | +32.8% | −27.8 pts | −27.0 pts |
| 6 months | −66.2% | −65.4% | −43.0% | −43.0% | −23.2 pts | −22.4 pts |
| 1 year | −85.2% | −84.4% | −64.5% | −64.5% | −20.7 pts | −19.9 pts |
| Since launch | −89.8% | −90.2% | −81.5% | −87.6% | −8.3 pts | −2.6 pts |
| CRCA ProShares Ultra CRCL Aims to return twice the daily move of CRCL | CRCG Leverage Shares 2X Long CRCL Daily ETF Aims to return twice the daily move of CRCL | |
|---|---|---|
| Issuer | ProShares | Leverage Shares |
| Sets out to return | +2x | +2x |
| On | CRCL | CRCL |
| Segment | company | company |
| Fund returned, 3 months | +4.9% | +5.8% |
| Underlying returned, 3 months | +16.4% | +16.4% |
| What the stated multiple implies, 3 months | +32.8% | +32.8% |
| Difference from stated, 3 months | −27.8 pts | −27.0 pts |
| Fund returned, 1 year or since launch | −85.2% | −84.4% |
| Difference from stated, over that window | −20.7 pts | −19.9 pts |
| Underlying volatility | 89% | 89% |
| Difference over the days both have traded | −6.4 pts | −6.4 pts |
| Expense ratio | not published | 0.78% |
| Launched | Aug 7, 2025 | Aug 11, 2025 |
CRCA in plain words
Three months to Sep 11, 2026: CRCA returned +4.9% where its own daily promise gave +10.8%, 5.9 points short. Read the multiple against the whole window instead and +2 times CRCL's 16.4% implies +32.8%, which makes CRCA look 27.8 points short. 21.9 of that is daily compounding, which happens to any +2 times fund over the same path, and the rest is the fund. CRCA aims to return +2 times CRCL's move each day, then resets. Over one day it does that. Over longer, the daily results compound, so the total is not +2 times the period's move: in a market that falls and comes back it is reliably less, and in a steady run it can be more. CRCL moved at 89% annualized over that window. That is what decides how far the two figures separate: the same fund on a calm underlying and a violent one is a different product.
CRCG in plain words
Three months to Sep 11, 2026: CRCG returned +5.8% where its own daily promise gave +10.8%, 5.0 points short. Read the multiple against the whole window instead and +2 times CRCL's 16.4% implies +32.8%, which makes CRCG look 27.0 points short. CRCG aims to return +2 times CRCL's move each day, then resets.
Questions people ask
- Which came closer to its stated multiple, CRCA or CRCG?
- Over the window to Sep 11, 2026, CRCA finished 27.8 points from what its multiple implies and CRCG finished 27.0 points from its own, so CRCG came closer. Neither figure predicts the next window: it depends on how much the underlying moves about.
- Are CRCA and CRCG levered on the same thing?
- Yes. Both are levered on CRCL, CRCA at +2 times and CRCG at +2 times the daily move.
- Which one decays faster, CRCA or CRCG?
- Decay follows how much the underlying moves about. Over this window CRCA’s moved at 89% annualized and CRCG’s at 89%, so CRCA has the rougher ride and, at the same multiple, loses more to compounding.
- Can I hold CRCA or CRCG for a year?
- Both reset every day, so the multiple in the name applies to a single day and the daily results compound. Over a year the total is not the multiple times the year’s move, and in a market that falls and comes back it is reliably less. ETFIQ makes no recommendation either way.
Other comparisons
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, CRCA against CRCG, data as of Sep 11, 2026. https://etfiq.com/compare/leverage/CRCA-CRCG Free to use with attribution; the underlying files are at Open data.